Avoid Chemcel Biotech IPO: Anand Rathi
Chemcel Biotech has opened for subscription with its initial public offering (IPO) of 15.40 million equity shares of Rs 10 each. Anand Rathi Securities has come out with a research report on Chemcel Biotech\’s IPO. It has recommended investors to ignore the issue.
